Novozymes growth driver finally driving some growth

Slowly but surely, the Danish biotech company's venture into biofuels is starting to show growth in sales. This solidifies what seems to be a turning point after several years of disappointment on the market, says Novozymes CEO Peder Holk Nielsen.

Danish biotech company Novozymes has struggled for years in its business for enzymes produced for second-generation biofuels. But now it seems a breakthrough is near, says CEO Peder Holk Nielsen, who presented the company's first quarter interim report Wednesday.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading

Jobs

See all jobs